Internal Medicine, Hematology & Oncology · Vallejo, CA
NPI
1780949131
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
975 Sereno Dr., Mob Suite 210 Dept of Oncology
Vallejo, CA, 94589
Phone (707) 651-1077
Groups this clinician bills Medicare through
Medicare paid, 2023
$3,628
877 services
Medicare patients, 2023
12
Average age 65
Drug cost, 2024
$6.6M
1,240 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Daniel J Lee prescribed most often to Medicare patients was Hydroxyurea, with 177 prescriptions and refills. In total Daniel J Lee wrote 1,240 Medicare prescriptions that cost $6.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxyurea Generic | 177 | 465 | 52 | $6,499 |
| Lenalidomide Generic | 128 | 128 | 18 | $1.5M |
| Dexamethasone Generic | 103 | 127 | 30 | $1,967 |
| Brukinsa Zanubrutinib | 81 | 81 | Under 11 | $1.1M |
| Acyclovir Generic | 69 | 162 | 28 | $1,989 |
| Pomalyst Pomalidomide | 54 | 54 | 11 | $1.3M |
| Prochlorperazine Maleate Generic | 53 | 53 | 28 | $751 |
| Alvaiz Eltrombopag Choline | 38 | 40 | Under 11 | $155K |
| Deferasirox Generic | 29 | 30 | Under 11 | $39K |
| Promacta Eltrombopag Olamine | 29 | 29 | Under 11 | $274K |
| Jakafi Ruxolitinib Phosphate | 28 | 28 | Under 11 | $413K |
| Calquence Acalabrutinib Maleate | 26 | 26 | Under 11 | $374K |
| Imbruvica Ibrutinib | 23 | 23 | Under 11 | $273K |
| Omeprazole Generic | 22 | 29 | Under 11 | $282 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $493 |
Brand drugs: - claims; generic drugs: 835 claims; opioid claims: 51.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel J Lee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.